Evidence map›Paper›PMID 39294623›Full record

ArticleBMC cancer2024

Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy.

Yufei Chen, Chao Ma, Panpan Yang, Kuanzheng Mao, Yisha Gao, Luguang Chen, Zhen Wang, Yun Bian, Chengwei Shao, Jianping Lu

Abstract read
In one paragraph

Article in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. MRI for restaging pancreatic cancer.Insights into imaging · 2026
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yufei ChenCollege of Electronic and Information Engineering, Tongji University, Shanghai, China.
Chao MaCollege of Electronic and Information Engineering, Tongji University, Shanghai, China. mengqihi@gmail.com.
Panpan YangDepartment of Radiology, Changhai Hospital of Shanghai, Naval Medical University, Changhai Road 168, Shanghai, 200434, China.
Kuanzheng MaoDepartment of Radiology, Changhai Hospital of Shanghai, Naval Medical University, Changhai Road 168, Shanghai, 200434, China.
Yisha GaoDepartment of Pathology, Changhai Hospital of Shanghai, Naval Medical University, Shanghai, China.
Luguang ChenDepartment of Radiology, Changhai Hospital of Shanghai, Naval Medical University, Changhai Road 168, Shanghai, 200434, China.
Zhen WangDepartment of Radiology, Changhai Hospital of Shanghai, Naval Medical University, Changhai Road 168, Shanghai, 200434, China.
Yun BianDepartment of Radiology, Changhai Hospital of Shanghai, Naval Medical University, Changhai Road 168, Shanghai, 200434, China.
Chengwei ShaoDepartment of Radiology, Changhai Hospital of Shanghai, Naval Medical University, Changhai Road 168, Shanghai, 200434, China.
Jianping LuDepartment of Radiology, Changhai Hospital of Shanghai, Naval Medical University, Changhai Road 168, Shanghai, 200434, China.

Funding

234 Platform Discipline Consolidation Foundation Project of Changhai Hospital 2020YPT001National Natural Science Foundation of China 82073307, 62173252Shanghai Science and Technology Innovation Action Plan Medical Innovation Research Project 20Y11912500
6 · The paper itself

Abstract

backgroundTo investigate the values of apparent diffusion coefficient (ADC) for the treatment response evaluation in pancreatic cancer (PC) patients receiving neoadjuvant therapy (NAT).

methodsThis study included 103 NAT patients with histologically proven PC. ADC maps were generated using monoexponential diffusion-weighted imaging (b values: 50, 800 s/mm

resultsThe minimum, maximum, and mean ADC values all increased dramatically after NAT, rising from 23.4 to 25.4% (all p < 0.001): mean (average: 1.626 × 10

conclusionsThe ADC values of PC increased significantly following NAT; however, the percentage increases failed to provide any predictive value for the resection margin status or TRG levels.

Indexed as

Diffusion Magnetic Resonance ImagingNeoadjuvant TherapyPancreatic NeoplasmsAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsFemaleHumansMaleMiddle AgedNeoplasm StagingRetrospective StudiesTreatment OutcomeApparent diffusion coefficientDiffusion weighted imagingNeoadjuvant therapyPancreatic cancerPrediction

Identifiers

PMID39294623
PMCPMC11412028

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.